Jennifer currently holds the title of Vice President of Intellectual Property and Global Head IP Counsel for Genetic Disease and Ophthalmology at Shire. She is an experienced patent attorney in the fields of biotechnology and rare disease, and her practice includes advising senior management on various matters relating to intellectual property, as well as portfolio development, life cycle management, litigation and IPR practice, licensing and agreement work, and corporate development support. Prior to joining Shire in 2011, Jen was at Pfizer (previously Wyeth), where she was Senior Corporate Counsel and Patent Lead for the Inflammation & Immunology Research Unit. She also held associate positions in the private law firms of Kirkpatrick & Lockhart, Testa, Hurwitz & Thibeault, and Hogan & Hartson (now Hogan Lovells). Jen received her degree in Biology, with an emphasis on molecular biology and genetics, from the University of Maryland at College Park and her JD magna cum laude from the Catholic University of America. Before attending law school, she worked as a research associate in human genome sequencing department at Human Genome Sciences. She is a member of the Massachusetts, Maryland and DC bars, and is registered to practice before the US Patent and Trademark Office.
4:30 PM–5:30 PM Jun 5, 2018 (US - Eastern)